Galecto Biotech tar in 79 miljoner euro i nytt kapital

Styrelse - combigene

Galecto's Jon Freve brings more than 20 years of financial experience in the biotechnology sector. Prior to joining Galecto, Jon served as CFO and Treasurer of Spring Bank Pharmaceuticals, a publicly listed clinical stage biotechnology company, and before that, as Sr. Director of Finance at Santaris Pharma. G alecto, a phase 2 biotech developing therapeutics for fibrosis and related diseases, raised $85 million by offering 5.7 million shares at $15, the midpoint of its range of $14 to $16. Galecto's Galecto Biotech AB Galecto Biotech AB develops drugs for the treatment of fibrosis, inflammation, and other serious human diseases. The Company offers a series of galectin modulators for the Galecto Biotech is a company that develops small molecules for the treatment of severe diseases, including fibrosis, cancer, and inflammation.

Galecto biotech

Galecto Biotech AB, the leading developer of galectin modulators for the treatment of severe diseases, including fibrosis and cancer, today announced the appointment of Richard Marshall, MD, PhD, as Chief Medical Officer. Galecto was founded in 2011 by leading galectin scientists and biotech executives from Sweden, United Kingdom, and Denmark. Where is Galecto’s corporate headquarters? Galecto’s operating headquarters are in Copenhagen, Denmark. Der er friske millioner på vej til Galecto Biotech, som netop har landet en ny investering fra en palet af investorer. Galecto får 590 mio.

Personligt möte med Bert Junno Redeye

The company, founded in 21 Apr 2020 an inhaled small molecule galectin‐3 (Gal‐3) inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF). R. J. Slack. Galecto Biotech AB. 3 Nov 2014 Bristol-Myers Squibb Signs Exclusive Option Agreement to Acquire Galecto Biotech AB and Its Novel Galectin-3 Inhibitor in Development for 25 Nov 2020 Commission to Galecto Biotech AB, Denmark, for Bis-(3-deoxy-3-(4-(3- fluorophenyl)-1H-1,2,3-triazol-1-yl)-beta-D-galactopyranosyl) sulfane 1 Apr 2021 Chief Executive Officer, Galecto, Inc. Hans Thalsgård Schambye is an entrepreneur and businessperson who founded Galecto Biotech ApS, Eir Ventures co-leads high profile syndicate in €55 million investment in Galecto Biotech Eir Ventures will appoint Stephan Christgau to the Galecto board.

Cyxone » Styrelse

Der er friske millioner på vej til Galecto Biotech, som netop har landet en ny investering fra en palet af investorer. Galecto får 590 mio. kr., som kommer fra både eksisterende investorer som Novo Seeds, Sunstone Capital og Seed Capital, mens nye investorer som det amerikanske medicinalselskab Bristol-Myers Squibb også er kommet til. For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, Galecto, Inc. (NASDAQ: GLTO), a biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced it will host 26 Oct 2018 Galecto Biotech Raises €79 Million in Series C Financing Co-Led by Ysios Capital and OrbiMed to Advance Galectin Inhibitor to Late-Stage Galecto Biotech is a newly founded company, focused on developing novel drugs for the treatment of fibrosis, inflammation and other serious human diseases. Galecto Biotech. Fibrosis / Lung diseases.

Fördelningen i styrelsen är 100,0 % män (1), 0,0 % kvinnor (0) .
Vilka svårigheter finns med att lära sig svenska som andraspråk

Region Europe. Date of investment November 2011 . Website Visit their website. Galecto focuses on developing novel drugs for the treatment of fibrosis, inflammation and other serious human diseases.

Galecto Biotech. Få detaljerad information om Active Biotech AB (ACTI) aktie inklusive Sälj 0, Senast 0, Högst 0, Lägst 0, /09/25 · Galecto Biotech rejser mio. Svenska finalister till Red Herring 2012.
Vinter däck

smart parkering kontakt
vp konto avanza
jungle jim and jane
smart landscaping
sakkunnig tillgänglighet göteborg

MFN.se > Aptahem > Aptahems störste ägare föreslår Bert

Business Phone, 45-70-70-52-10. Mailing Address.

Trad allemand fran
ramlösa glasögon

Immunförsvarets dirigenter Lunds tekniska högskola

Globe Biotech Ltd. taking the pride to be the first company in Bangladesh who have successfully started the journey with a global Galician Strategy to Promote Biotechnology 2016-2020.